Merck broke AIDS drug price promise, says MSF.
Ahmad
Khabir
K
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D000480:Alkynes; D019380:Anti-HIV Agents / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use; D048588:Benzoxazines; D003521:Cyclopropanes; D003906:Developing Countries / Q000191:economics / Q000706:statistics & numerical data; D016527:Drug Costs / Q000706:statistics & numerical data; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence / Q000639:trends; D006801:Humans; D010078:Oxazines / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use; D015995:Prevalence
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz